Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

7

Number of overlapping holdings

30.4%

% of XDNA's 23 holdings also in ARKG

18.9%

% of ARKG's 39 holdings also in XDNA

Overlap by Weight
Sector Drift (XDNA minus ARKG)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XDNA
Weight
in ARKG
Overlap
CRISPR THERAPEUTICS AG 15.1% 6.4% 6.4%
INTELLIA THERAPEUTICS, INC. 8.7% 4.2% 4.2%
BEAM THERAPEUTICS, INC. 13.7% 3.3% 3.3%
VERTEX PHARMACEUTICALS INC 1.5% 2.7% 1.5%
VERVE THERAPEUTICS, INC. 4.5% 1.3% 1.3%

Position Highlights (Non-Overlapping Exposures)
XDNA Overweight Relative to ARKG
BEAM THERAPEUTICS, INC. 10.4%
THERMO FISHER SCIENTIFIC INC 9.5%
CRISPR THERAPEUTICS AG 8.7%
EDITAS MEDICINE, INC. 5.7%
CARIBOU BIOSCIENCES, INC. 4.7%
PRIME MEDICINE, INC. 4.6%
INTELLIA THERAPEUTICS, INC. 4.5%
POSEIDA THERAPEUTICS, INC. 4.1%
ABBVIE INC 3.8%
ALLOGENE THERAPEUTICS, INC. 3.4%
XDNA Underweight Relative to ARKG
TWIST BIOSCIENCE CORP. -8.2%
CAREDX, INC. -6.2%
RECURSION PHARMACEUTICALS, INC CLASS -5.7%
SCHRODINGER, INC. -4.1%
IONIS PHARMACEUTICALS, INC. -3.9%
EXACT SCIENCES CORP -3.8%
10X GENOMICS INC CLASS A -3.5%
ALCOBRA LTD -3.4%
MODERNA, INC. -3.3%
VERACYTE INC -3.0%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY